Luke Farrow, Jemma Hudson, Alan George, Mike R Reed, Marion K Campbell
{"title":"Clinical trials in Trauma and Orthopaedics : time to think Bayesian?","authors":"Luke Farrow, Jemma Hudson, Alan George, Mike R Reed, Marion K Campbell","doi":"10.1302/0301-620X.107B9.BJJ-2025-0548.R1","DOIUrl":null,"url":null,"abstract":"<p><p>This aim of this annotation is to provide greater knowledge about Bayesian methodology when used in the design of clinical trials and in the analysis of the findings, including the potential benefits and limitations of this approach in Trauma and Orthopaedic surgery. We outline how adopting Bayesian methodology could serve as a feasible and potentially more relevant basis for the design and conduct of future randomized controlled trials in our specialty. It also provides background methodological context for the paper 'High-dose dual-antibiotic cement for hip hemiarthroplasty: a post-hoc Bayesian analysis of a randomized controlled trial', which is published in this issue.</p>","PeriodicalId":48944,"journal":{"name":"Bone & Joint Journal","volume":"107-B 9","pages":"862-864"},"PeriodicalIF":4.6000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bone & Joint Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1302/0301-620X.107B9.BJJ-2025-0548.R1","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
引用次数: 0
Abstract
This aim of this annotation is to provide greater knowledge about Bayesian methodology when used in the design of clinical trials and in the analysis of the findings, including the potential benefits and limitations of this approach in Trauma and Orthopaedic surgery. We outline how adopting Bayesian methodology could serve as a feasible and potentially more relevant basis for the design and conduct of future randomized controlled trials in our specialty. It also provides background methodological context for the paper 'High-dose dual-antibiotic cement for hip hemiarthroplasty: a post-hoc Bayesian analysis of a randomized controlled trial', which is published in this issue.
期刊介绍:
We welcome original articles from any part of the world. The papers are assessed by members of the Editorial Board and our international panel of expert reviewers, then either accepted for publication or rejected by the Editor. We receive over 2000 submissions each year and accept about 250 for publication, many after revisions recommended by the reviewers, editors or statistical advisers. A decision usually takes between six and eight weeks. Each paper is assessed by two reviewers with a special interest in the subject covered by the paper, and also by members of the editorial team. Controversial papers will be discussed at a full meeting of the Editorial Board. Publication is between four and six months after acceptance.